Table II. Potential fusion-derived peptides identified in leukemia cell lines.
| Sample | Fusion gene | Chr. | Fusion junction | Junction boundary | Peptide type | Peptide sequence | # of spectra |
|---|---|---|---|---|---|---|---|
| Jurkat | FAM133B:CDK6 | 7–7 | 92581506–92774831 | Exon-Exon | Fusion junction peptide | PTW:LFDVCTVSR | 2 |
| Jurkat | FAM24B:CUZD1 | 10–10 | 122855745–122839231 | Exon-Exon | Frameshift peptide | KGLKVTHRPAC | 1 |
| K562 (Slavoff) | HNRNPA1P13:HNRNPA2B1 | 5–7 | 136429638–26193641 | Exon-Exon | Fusion junction peptide | ALVVVDMVAVGMAIMDMV:VEDLDMATR | 1 |
| K562 (Slavoff) | HNRNPA1P58:HNRNPA2B1 | 6–7 | 24002209–26195899 | Exon-Exon | Peptide of pseudogene | QEMVSASSSQRGR | 3 |
| K562 (Berger) | RPL14:NCOR2 | 3–12 | 40462013–124402538 | Exon-Exon | Fusion junction peptide | ASPKKA:AAAAAAAH | 2 |
| K562 (Berger) | C20orf203:NOL4L | 20–20 | 32632893–32527913 | Exon-5'UTR | Frameshift peptide | LGEDLGV | 2 |